RESUMEN
sigma receptors may represent an exciting new approach for the development of novel psychotherapeutic agents. Unfortunately, many of the commonly used sigma ligands lack selectivity (e.g., many bind at phencyclidine or dopamine receptors) or suffer from other serious drawbacks. Recently, we described a series of 2-phenylaminoethanes that bind at sigma receptors with high affinity and selectivity. Because there is evidence that 1-phenylpiperazines can structurally mimic the 2-phenylaminoethane moiety, we prepared a series of 1-phenylpiperazines and related analogues and incorporated structural features already shown to enhance the sigma binding of the 2-phenylaminoethanes. Several of these derivatives bind at sigma receptors with high affinity (Ki = 1-10 nM) and lack appreciable affinity for phencyclidine and dopamine receptors. In as much as certain of these agents structurally resemble the high-affinity, but nonselective, sigma ligand haloperidol, and because they bind with 10 times the affinity of haloperidol, we have apparently identified what appears to be the primary sigma pharmacophore of that agent.
Asunto(s)
Piperazinas/metabolismo , Piperidinas/metabolismo , Receptores Opioides/metabolismo , Animales , Cobayas , Técnicas In Vitro , Ligandos , Piperazinas/síntesis química , Piperidinas/síntesis química , Ensayo de Unión Radioligante , Receptores Dopaminérgicos/metabolismo , Receptores de Neurotransmisores/metabolismo , Receptores de Fenciclidina , Receptores sigma , Relación Estructura-ActividadRESUMEN
Certain benzomorphans, such as N-allylnormetazocine, are classical "sigma-opiates" that bind both at sigma and phencyclidine (PCP) binding sites with modest affinity. Recently, we identified N-substituted 2-phenylaminoethane as being the primary sigma-pharmacophore of the benzomorphans and demonstrated that 1-phenyl-2-aminopropane (2) derivatives, depending upon their terminal amine substituents, constitute a novel class of high-affinity sigma-selective agents. With this pharmacophore, it is shown in the present investigation that the aromatic hydroxyl group (a prime feature of all the sigma-opiates) contributes little to the binding of 2 at sigma-sites. It is also demonstrated that an N-substituted aminotetralin moiety (such as 17, a conformationally restricted analogue of 2) may also be considered a sigma-opiate pharmacophore. Unlike the sigma-opiates, derivatives of 2 and 17 display no affinity for PCP sites and must consequently lack those structural features important for the binding of benzomorphans at PCP sites. Because 3-phenylpiperidines and related sigma-ligands also possess a phenylalkylamine imbedded within their structures, we propose that the 2-phenylaminoethane moiety is a common sigma-pharmacophore for derivatives of 2, the 3-phenylpiperidines, and the sigma-opiates.
Asunto(s)
Propilaminas/metabolismo , Receptores Opioides/metabolismo , Animales , Encéfalo/metabolismo , Cobayas , Microsomas/metabolismo , Fenciclidina/metabolismo , Ensayo de Unión Radioligante , Receptores sigma , Especificidad por SustratoRESUMEN
With an eye toward the development of novel atypical antipsychotic agents, we have studied the structure-affinity relationships of N,N'-di-o-tolylguanidine (DTG, 3) and its congeners at the haloperidol-sensitive sigma receptor. A number of DTG analogues were synthesized and evaluated in in vitro radioligand displacement experiments with guinea pig brain membrane homogenates, using the highly sigma-specific radioligands [3H]-3 and [3H]-(+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine and the phencyclidine (PCP) receptor specific compounds [3H]-N-[1-(2-thienyl)-cyclohexyl]piperidine and [3H]-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10- imine. The affinity of N,N'-diarylguanidines for the sigma receptor decreases with increasing steric bulk of ortho substituents larger than C2H5. Hydrophobic substituents are generally preferred over similarly positioned hydrophilic ones. Furthermore, electroneutral substituents are preferred over strongly electron donating or withdrawing groups. Significant binding to the sigma receptor is usually retained as long as at least one side of the guanidine bears a preferred group (e.g. 2-CH3C6H5). Replacement of one or both aryl rings with certain saturated carbocycles (e.g. cyclohexyl, norbornyl, or adamantyl) leads to a significant increase in affinity. By combining the best aromatic and best saturated carbocyclic substituents in the same molecule, we arrived at some of the most potent sigma ligands described to date (e.g. N-exo-2-norbornyl-N'-(2-iodophenyl)guanidine, IC50 = 3 nM vs [3H]-3). All of the compounds tested were several orders of magnitude more potent at the sigma receptor than at the PCP receptor, with a few notable exceptions. This series of disubstituted guanidines may be of value in the development of potential antipsychotics and in the further pharmacological and biochemical characterization of the sigma receptor.
Asunto(s)
Antipsicóticos/síntesis química , Guanidinas/síntesis química , Animales , Antipsicóticos/farmacología , Fenómenos Químicos , Química , Guanidinas/farmacología , Cobayas , Haloperidol/farmacología , Ensayo de Unión Radioligante , Receptores Opioides/efectos de los fármacos , Receptores sigma , Relación Estructura-ActividadRESUMEN
A clone encoding a human D2 dopamine receptor was isolated from a pituitary cDNA library and sequenced. The deduced protein sequence is 96% identical with that of the cloned rat receptor with one major difference: the human receptor contains an additional 29 amino acids in its putative third cytoplasmic loop. Southern blotting demonstrated the presence of only one human D2 receptor gene. Two overlapping phage containing the gene were isolated and characterized. DNA sequence analysis of these clones showed that the coding sequence is interrupted by six introns and that the additional amino acids present in the human pituitary receptor are encoded by a single exon of 87 base pairs. The involvement of this sequence in alternative splicing and its biological significance are discussed.
Asunto(s)
Clonación Molecular , ADN/genética , Genes , Receptores Dopaminérgicos/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Unión Competitiva , Southern Blotting , Cuerpo Estriado/metabolismo , Domperidona/metabolismo , Exones , Biblioteca de Genes , Humanos , Cinética , Datos de Secuencia Molecular , Hipófisis/metabolismo , Ratas , Receptores Dopaminérgicos/metabolismo , Receptores de Dopamina D2 , Mapeo Restrictivo , Homología de Secuencia de Ácido NucleicoRESUMEN
Four diarylguanidine derivatives were synthesized. These compounds were found to displace, at submicromolar concentrations, 3H-labeled 1-[1-(2-thienyl)cyclohexyl]piperidine and (+)-[3H]MK-801 from phencyclidine receptors in brain membrane preparations. In electrophysiological experiments the diarylguanidines blocked N-methyl-D-aspartate (NMDA)-activated ion channels. These diarylguanidines also protected rat hippocampal neurons in vitro from glutamate-induced cell death. Our results show that some diarylguanidines are noncompetitive antagonists of NMDA receptor-mediated responses and have the neuroprotective property that is commonly associated with blockers of the NMDA receptor-gated cation channel. Diarylguanidines are structurally unrelated to known blockers of NMDA channels and, therefore, represent a new compound series for the development of neuroprotective agents with therapeutic value in patients suffering from stroke, from brain or spinal cord trauma, from hypoglycemia, and possibly from brain ischemia due to heart attack.
Asunto(s)
Guanidinas/síntesis química , Hipocampo/fisiología , Receptores de Neurotransmisores/efectos de los fármacos , Animales , Unión Competitiva , Encéfalo/metabolismo , Membrana Celular/fisiología , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Guanidinas/farmacología , Cobayas , Hipocampo/citología , Hipocampo/efectos de los fármacos , Indicadores y Reactivos , Cinética , Ratas , Receptores de N-Metil-D-Aspartato , Receptores de Neurotransmisores/metabolismo , Receptores de Fenciclidina , Relación Estructura-ActividadRESUMEN
The hemagglutinin-neuraminidase protein (HN) of mumps virus was purified by immunoaffinity chromatography and fragmented by the combined action of CNBr and trypsin. The resulting peptides were separated by HPLC and sequenced by automated Edman degradation. Using this HN-specific amino acid sequence data, a degenerate oligonucleotide was produced and subsequently used to screen a mumps virus cDNA library to isolate HN-specific clones. The complete nucleotide sequence of the HN gene was determined. The monocistronic HN mRNA is approximately 1900 nucleotides long and encodes a single open reading frame of 582 amino acids. The HN protein has a unique hydrophobic stretch of 19 amino acids at its N-terminus that apparently anchors the protein in the viral envelope. A comparison of the mumps virus HN protein sequence with the sequences of the other known paramyxovirus HNs indicates that mumps virus is most closely related to SV-5, followed in decreasing order by NDV, parainfluenza virus 3, and Sendai virus.
Asunto(s)
Genes Virales , Hemaglutininas Virales/genética , Virus de la Parotiditis/genética , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , ADN/genética , Datos de Secuencia Molecular , Fragmentos de Péptidos/análisisRESUMEN
The fusion protein (F) gene of mumps virus was cloned from a cDNA library constructed from infected cell mRNA. The F-specific plasmids were identified by hybridization to a degenerate oligonucleotide probe whose sequence was deduced from the N-terminal amino acid sequence of the F2 protein. The complete nucleotide sequence of the F gene was determined. The gene is 1786 nucleotides long and encodes one long open reading frame of 538 amino acids. The F protein has a 19-amino acid signal peptide cleaved between Cys and Val residues. The cleavage site for activation of the F0 protein into the mature F1,2 is Arg-Arg-His-Lys-Arg. A stretch of 30 hydrophobic amino acids near the C-terminus of the protein is followed by several charged amino acids and appears to serve as the anchoring domain for the protein in the lipid bilayer. The F gene of mumps virus is highly related to the F gene of the paramyxovirus SV-5.
Asunto(s)
Genes Virales , Virus de la Parotiditis/genética , Proteínas Virales de Fusión/genética , Secuencia de Aminoácidos , Secuencia de Bases , ADN/genética , Genes , Glicoproteínas/genética , Paramyxoviridae/genética , Conformación Proteica , ARN Mensajero/genética , ARN Viral/genética , Homología de Secuencia de Ácido NucleicoRESUMEN
Partial amino acid sequence analysis of epidermal growth factor binding protein (EGF-BP), an arginine esteropeptidase that specifically associates with EGF to form a high molecular weight complex in male mouse submandibular glands, has revealed a single, distinct protein that is different from three previously reported forms of EGF-BP. This protein shows substantial sequence homology with these other putative forms of EGF-BP as well as with a large family of kallikreins expressed in the mouse submandibular gland. Purified EGF-BP contains three polypeptide chains as a result of two internal cleavages at residues 87-88 and 140-141. These modifications may represent processing events that are critical for determining the binding specificity of EGF-BP, since they occur within regions surrounding the substrate binding site.
Asunto(s)
Endopeptidasas/metabolismo , Factor de Crecimiento Epidérmico/metabolismo , Glándula Submandibular/metabolismo , Secuencia de Aminoácidos , Animales , Endopeptidasas/aislamiento & purificación , Calicreínas , Masculino , Ratones , Relación Estructura-Actividad , Calicreínas de Tejido , Difracción de Rayos XRESUMEN
The fusion (F) protein of mumps virus was purified by immunoaffinity chromatography using an anti-F monoclonal antibody. The F protein was reduced and alkylated, and the F1 and F2 chains were isolated by high-pressure size exclusion chromatography. Twenty-three amino acid residues from the amino terminus of each chain were identified following automated Edman degradation. The amino-terminal sequence of the F1 chain was homologous to previously reported F1 sequences from three other paramyxoviruses (simian virus 5, Newcastle disease virus, and Sendai virus). Secondary structure predictions suggest an alpha-helical conformation for the mumps virus F1 amino-terminal sequence. A helical wheel model of the paramyxovirus F1 NH2 terminus is presented which defines conserved and variable arcs of the helix and provides a spatial representation of this critical functional domain of the paramyxovirus fusion protein.
Asunto(s)
Virus de la Parotiditis/análisis , Proteínas del Envoltorio Viral , Secuencia de Aminoácidos , Cromatografía de Afinidad , Cromatografía Líquida de Alta Presión , Sustancias Macromoleculares , Conformación Proteica , Proteínas del Envoltorio Viral/aislamiento & purificación , Proteínas Virales de FusiónRESUMEN
Newborn Syrian hamsters were challanged with an intracerebral inoculum containing 128 50% lethal doses of the Kilham strain of mumps virus and treated 24 h later with a single intraperitoneal injection of mouse monoclonal antibody. Monoclonal antibodies reactive with epitopes on the fusion glycoprotein of mumps virus could not inhibit hemagglutination or neutralize infectivity in vitro and failed to provide biologically important protection against the in vivo infection. In contrast, monoclonal antibodies reactive with epitopes on the hemagglutinin-neuraminidase glycoprotein of mumps virus inhibited hemagglutination and neutralized infectivity in vitro and protected infected animals from the otherwise lethal central nervous system virus infection. Similar protection was provided by both purified immunoglobulin and F(ab')2 fragments. Immuno-cytochemical and virological studies showed diminished virus antigen and virus titers in the brains of successfully treated animals. It appears that a topographically restricted region of the hemagglutinin-neuraminidase molecule of the Kilham strain of mumps virus is of critical importance for immune recognition by the infected host.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Glicoproteínas/inmunología , Meningoencefalitis/inmunología , Virus de la Parotiditis/inmunología , Paperas/inmunología , Animales , Anticuerpos Monoclonales/uso terapéutico , Antígenos Virales/análisis , Cricetinae , Femenino , Fragmentos Fab de Inmunoglobulinas/inmunología , Inmunoglobulina G/inmunología , Mesocricetus , EmbarazoRESUMEN
Mumps virus infection of the CV-1 cell line results either in no cytopathic effect or extensive cell fusion, depending upon the infecting mumps virus strain. Growth cycle analyses indicated that both types of infection were the result of multiple cycle replication of mumps virus. Intracellular virus-specific polypeptide synthesis was examined by pulse- and pulse-chase-labelling with radioactive amino acids and sugars. The major polypeptides seen on SDS-polyacrylamide gels were NP (69 000 mol. wt.), P (45 000 mol. wt.) and M (40 000 mol. wt.); a non-structural polypeptide (22 000 mol. wt.) was also present in infected cell lysates. The HN (74 000 to 79 000 mol. wt.) glycopolypeptide was detected in [3H]glucosamine- and [3H]mannose-labelled infected cells. A 65 000 mol. wt. species that had incorporated these precursors was seen in pulse-labelled infected cell lysates, and this glycopolypeptide vanished during the chase interval with the concomitant appearance of two glycopolypeptides (59 000 mol. wt. and 14 000 to 15 000 mol. wt.) which represented the F1 and F2 subunits of the F glycoprotein. Immunological data confirmed the relatedness of the 65 000 mol. wt. glycopolypeptide to the F glycoprotein and identified it as the precursor F0. The F0 precursor glycopolypeptide was seen in cells infected with both fusing and non-fusing strains, and F0 was processed completely to F glycoprotein for all infections. Thus, the lack of cell fusion after infection with certain mumps strains is not the consequence of incomplete processing of the F0 precursor.
Asunto(s)
Virus de la Parotiditis/genética , Proteínas Virales/genética , Animales , Línea Celular , Transformación Celular Viral , Chlorocebus aethiops , Glicopéptidos/genética , Riñón , Cinética , Peso Molecular , Especificidad de la Especie , Tritio , Proteínas Virales de Fusión , Proteínas Virales/aislamiento & purificaciónAsunto(s)
Antivirales/uso terapéutico , Enfermedades del Sistema Nervioso Central/tratamiento farmacológico , Virosis/tratamiento farmacológico , Transformación Celular Viral/efectos de los fármacos , Enfermedad Crónica , Replicación del ADN/efectos de los fármacos , ADN Viral/biosíntesis , Humanos , Inmunoterapia , Biosíntesis de Proteínas/efectos de los fármacos , ARN Mensajero/biosíntesis , ARN Viral/biosíntesis , Replicación Viral/efectos de los fármacosRESUMEN
A hybridoma cell line secreting antibody of the immunoglobulin G3 isotype with kappa light chains and with activity against the HN glycoprotein of the Kilham strain of mumps virus was established. The antibody exhibited structural homogeneity in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and had a microheterogeneous isoelectric spectrum characteristic of an antibody of monoclonal origin. The specificity of the monoclonal antibody, shown by immunoprecipitation performed with radiolabeled virus and infected cell lysates, was for the larger mumps virus glycoprotein. In functional assays the antibody inhibited the hemagglutinating and neuraminidase activities and neutralized the infectivity of the homologous Kilham strain of virus and clearly differentiated this strain from two heterologous strains, Enders and O'Take. The antibody was markedly less effective with the O'Take strain than with either the Kilham or Enders strain in inhibiting both hemagglutination and neuraminidase activity against the macromolecular substrate fetuin. The inhibition of the neuraminidase activity of the Kilham strain was independent of substrate size, the antibody inhibiting the hydrolysis of both fetuin and the trisaccharide neuraminlactose. By contrast, the antibody did not inhibit the hydrolysis of neuraminlactose by the two heterologous mumps strains. These results provide the first demonstration of antigenic differences between mumps virus strains and highlight the utility of monoclonal antibody in analyzing the structural basis underlying functional activities of the HN glycoproteins.
Asunto(s)
Anticuerpos Monoclonales , Anticuerpos Antivirales , Glicoproteínas/inmunología , Vacuna contra la Parotiditis/inmunología , Proteínas Virales/inmunología , Especificidad de Anticuerpos , Antígenos Virales/análisis , Epítopos , Pruebas de Inhibición de Hemaglutinación , Virus de la Parotiditis/clasificación , Neuraminidasa/antagonistas & inhibidores , Pruebas de NeutralizaciónRESUMEN
A 58-year-old man developed recurrent episodes of symmetrical motor weakness associated with acroparesthesias and areflexia. The cerebrospinal fluid protein was elevated and nerve conduction velocities were slowed. There was no evidence of systemic disease or toxic exposure, and a diagnosis of chronic relapsing inflammatory polyradiculoneuropathy was made. The patient improved during treatment with corticosteroids, but steroid-induced complications necessitated discontinuance. A recrudescence of symptoms prompted a search for alternative therapy, and plasma exchange was tried. A marked improvement in strength was noted following each course of plasma exchange, suggesting that further similar trials are justified.
Asunto(s)
Plasmaféresis , Polirradiculoneuropatía/terapia , Enfermedad Crónica , Humanos , Masculino , Persona de Mediana Edad , Polirradiculoneuropatía/tratamiento farmacológicoAsunto(s)
Factores de Crecimiento Nervioso , Neoplasias de las Glándulas Suprarrenales/etiología , Adulto , Animales , Técnicas de Cultivo , Humanos , Hipotensión Ortostática/etiología , Lactante , Masculino , Regresión Neoplásica Espontánea , Factores de Crecimiento Nervioso/análisis , Factores de Crecimiento Nervioso/fisiología , Factores de Crecimiento Nervioso/uso terapéutico , Sistema Nervioso/fisiopatología , Enfermedades del Sistema Nervioso/etiología , Enfermedades del Sistema Nervioso/genética , Enfermedades del Sistema Nervioso/fisiopatología , Neuroblastoma/tratamiento farmacológico , Neuroblastoma/etiología , Neurofibromatosis 1/etiología , Feocromocitoma/etiología , Células Receptoras SensorialesAsunto(s)
Factores de Crecimiento Nervioso , Secuencia de Aminoácidos , Animales , Sitios de Unión , Células Cultivadas , Fenómenos Químicos , Química , Embrión de Pollo , Ganglios Espinales/citología , Ganglios Espinales/embriología , Humanos , Ratones , Mitosis , Degeneración Nerviosa , Factores de Crecimiento Nervioso/farmacología , Factores de Crecimiento Nervioso/fisiología , Neuronas/citología , Neuronas/ultraestructura , Conejos , Sarcoma Experimental/patología , Sarcoma Experimental/ultraestructura , Células Receptoras Sensoriales/fisiología , Factores de TiempoAsunto(s)
Factores de Crecimiento Nervioso , Animales , Animales Recién Nacidos , Transporte Axonal , Axones/fisiología , Sitios de Unión , Movimiento Celular , Sistema Nervioso Central/fisiología , Ganglios Autónomos/embriología , Ganglios Autónomos/crecimiento & desarrollo , Ganglios Autónomos/metabolismo , Humanos , Sueros Inmunes , Mitosis , Terminaciones Nerviosas/fisiología , Factores de Crecimiento Nervioso/metabolismo , Factores de Crecimiento Nervioso/farmacología , Factores de Crecimiento Nervioso/fisiología , Neuronas/citología , Neuronas/metabolismo , Neuronas/ultraestructura , Sarcoma Experimental/patología , Células Receptoras Sensoriales/fisiología , Simpatectomía , Sistema Nervioso Simpático/efectos de los fármacos , Sistema Nervioso Simpático/embriología , Sistema Nervioso Simpático/crecimiento & desarrolloAsunto(s)
Factores de Crecimiento Nervioso , Secuencia de Aminoácidos , Animales , Fenómenos Químicos , Química , Insulina , Ratones , Peso Molecular , Factores de Crecimiento Nervioso/biosíntesis , Factores de Crecimiento Nervioso/aislamiento & purificación , Factores de Crecimiento Nervioso/farmacología , Conformación Proteica , Receptores de Droga , Venenos de Serpiente/metabolismo , Glándula Submandibular/metabolismo , ZincRESUMEN
The gamma subunits of the 7S nerve growth factor complex (7S NGF) display arginine esteropeptidase activity. By varying the conditions of electrophoresis in acrylamide gel, it has been demonstrated that the gamma-subunit fraction of 7S NGF contains five different proteins, in contrast to the three (gamma1, gamma2, and gamma3) originally described (Smith, A.P., Varon, S. and Shooter, E.M. (1968), Biochemistry 7, 3259-3268); the gamma1 and gamma2 subunits, previously thought to be single species, can each be resolved into two components. The two components of the gamma1 subunit have the same isoelectric point, as do the two components of the gamma2 subunit. The distribution of protein among the two components of each of the gamma1 and gamma2 subunits varied from preparation to preparation. Moreover, a shift in the distribution for the gamma1 subunit was accompanied by a parallel shift for the gamma2 subunit. All of the different gamma proteins have the same molecular weight. On the basis of the molecular weights of the peptide chains of the gamma subunits and of the species which are formed by cross-linking with dimethyl suberimidate, it was concluded, that both the gamma1 and gamma2 subunits contain one species with two peptide chains and another with three peptide chains, while the gamma3 subunit is a single species with three peptide chains. The results also suggest that two of the chains in the three-chain species are derived, by proteolytic cleavage, from the larger chain in the two-chain species.
Asunto(s)
Factores de Crecimiento Nervioso , Aminoácidos/análisis , Sitios de Unión , Focalización Isoeléctrica , Sustancias Macromoleculares , Peso Molecular , Factores de Crecimiento Nervioso/aislamiento & purificación , Factores de Crecimiento Nervioso/metabolismo , Péptido Hidrolasas/metabolismo , Unión Proteica , Conformación Proteica , Compuestos de Sulfhidrilo/análisisRESUMEN
The epidermal growth factor (EGF) can be isolated from the submaxillary gland of the adult male mouse as part of a high molecular weight complex (HMW-EGF). This complex can be reversibly dissociated into its subunits, EGF AND EGF-binding protein, an arginine esteropeptidase (Taylor, J. M., Cohen, S., and Mitchell, W. M. (1970) Proc. Natl. Acad. Sci. U. S. A. 67, 164-171). The COOH-terminal arginine residue of EGF was quantitatively removed by digestion with carboxypeptidase B...